Metronom

Skip To Content

Troy Bremer, Chief Scientific Officer

Troy Bremer is co-founder and Chief Scientific Officer at Metronom Health, and has been an integral part of the company since its inception.

Troy's research background has involved the application of machine learning, statistical pattern recognition, modeling and biostatistics to molecular biology. He has expertise in the planning, management, analysis and execution of complex research and development programs.

Troy has extensive experience in diagnostic development and previously identified and validated several biomarker panels for disease prognosis and treatment response in oncology, leading to a number of publications and various patents. He is also co-founder and Chief Scientific Officer for PreludeDx. Before that, he worked at Lion Biosciences and Prediction Sciences where he served as Director of Research and Development.

Troy received his Doctorate in Biomedical Engineering from the University of California, San Diego.

Alert

You are now leaving the website of Metronom Health, Inc. and entering a third-party website over which Metronom Health, Inc. has no control. Neither Metronom Health, Inc. nor its subsidiaries or affiliates, are responsible for the content of third-party websites hyperlinked from this page or any hyperlink contained in a hyperlinked website, nor do they guarantee or endorse the information, recommendations, products or services offered on third-party websites.

Continue Cancel